We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Hematological Ratios Associated with Mortality in Pediatric Trauma Patients

By LabMedica International staff writers
Posted on 14 Nov 2019
Print article
Image: A blood film showing neutrophils and lymphocytes and other white and red blood cells, and a platelet (Photo courtesy of University of Minnesota).
Image: A blood film showing neutrophils and lymphocytes and other white and red blood cells, and a platelet (Photo courtesy of University of Minnesota).
Trauma-related injury as a potential cause of death affects millions of people worldwide, especially in less developed countries and furthermore, it is the leading cause of mortality in pediatric trauma patients.

The hematological parameters, the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) (as a new marker of inflammatory status), have been investigated to examine the prediction ability of systemic inflammatory response in many other disorders, including malignant cancers and pulmonary diseases.

An emergency physician at the Sivas Cumhuriyet University Hospital (Sivas, Turkey) evaluated the prognostic ability of NLR and PLR on mortality in pediatric trauma (PT) patients. This retrospective study included a total of 358 PT patients admitted to the emergency department (ED) of the hospital, between January 2010 and June 2018, due to acute trauma.

Data for hemoglobin (Hb), neutrophil, monocyte, white blood cell (WBC), lymphocyte, blood glucose, alanine aminotransferase (ALT), aspartate aminotransferase (AST), activated partial thromboplastin time (aPTT), and international normalized ratio (INR) were retrospectively derived from the medical record database of the first electronic application of biochemical results. Both the NLR and PLR were calculated at the time of admission by dividing the blood neutrophil count and the blood platelet count, respectively, by the lymphocyte count. The data regarding absolute neutrophil count and absolute lymphocyte count were obtained from the first routine blood assay at the time of admission.

The scientists reported that the NLR and PLR values were significantly higher in survivors than in non-survivors (NLR, 6.2±5.7 versus 2.6±2.5; PLR, 145.3±85.0 versus 46.2±25.2. The NLR (odds ratio [OR], 3.21 ;) PLR (OR, 0.90) blood glucose (OR, 1.02), and Injury Severity Score (ISS) (OR, 1.28)) were independent predictors of the mortality risk in PT patients. The area under the curve in the ROC curve analysis was 0.764 with a cut-off of 2.77 (sensitivity 70%, specificity 77%) for the NLR; and 0.928 with a cut-off of 61.83 (sensitivity 90%, specificity 85%) for the PLR.

The author concluded that acquiring the NLR and PLR at the time of admission could be a useful predictor for mortality in PT patients. The study indicated that NLR and PLR, as well as blood glucose and ISS at the time of admission, were independently associated with post-traumatic systemic inflammatory response syndrome (SIRS). The study was published in the October 2019 issue of the Rambam Maimonides Medical Journal.

Related Links:
Sivas Cumhuriyet University Hospital

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centromere B Assay
Centromere B Test
New
H.pylori Test
Humasis H.pylori Card

Print article

Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.